Characterization of putative Wnt3a-Inducible Enhancers by Lee, Katelynn C et al.
Characterization of putative Wnt3a-Inducible Enhancers 
Katelynn Lee¹, Nicholas Hum², Aimy Sebastian², Gabriela Loots² 
¹California Polytechnic State University San Luis Obispo, CA. ²BBTD, Lawrence Livermore National Laboratory, Livermore, CA. 
Introduction and Background 
 
The Wnt signaling pathway has been previously shown to play a major 
role in regulating bone metabolism and it is emerging as a target for the 
therapeutic intervention of bone thinning disorders such as osteoporosis. 
Several Wnt proteins have been shown to be expressed in bone and 
mutations in Wnt pathway members such as Wnt co-receptor Lrp5 and 
Wnt inhibitor Sost have been shown to be associated with low or high 
bone mass disorders, however, very little is known about specific roles 
played by different Wnt ligands in bone development, repair and 
remodeling. To identify downstream targets of Wnt signaling we 
sequence RNA synthesized by  Wnt3a treated osteoblasts and found 214 
genes to be significantly up-regulated by >2-fold in the presence of 
Wnt3a ligand. Computational analysis of ChipSeq data in the loci of 
these 214 genes predicted 163 putative Wnt-inducible enhancers. In this 
project, we sought to functionally validate these putative enhancer 
elements that may account for the Wnt3a-dependent activation of these 
214 transcripts. Candidate enhancers were cloned, transfected  into 
osteoblast-like cell lines, and examined for transgene expression in the 
presence and absence of recombinant Wnt3a protein. Preliminary data 
suggests that several noncoding elements may have enhancer properties 
both in the absence or presence of Wnt3a, in vitro.  
 
• Osteoblasts are bone cells responsible for bone formation. 
• Wnt describes a family of highly conserved proteins that regulate cell 
proliferation, fate specification, polarity, and migration. 
• Wnt signal stimulates several intra-cellular signal transduction 
cascades, including the canonical or Wnt/β-catenin dependent 
pathway. 
 
 
 
 
 
 
 
 
 
 
 
 
• Enhancers are distal regulatory elements that bind transcription factors 
and increase the rate of transcription of genes. 
• 20 putative enhancer regions were selected based on close proximity 
to a gene up-regulated by Wnt3a administration, the presence of 
TCF/LEF binding sites, DNAse hypersensitivity, as well as 
methylation and acetylation markers.  
 
 
 
 
 
 
 
 
 
Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Expression level in relative light units of reporter gene 
driven by enhancer constructs in the absence of Wnt3a. 
Significant increase in expression shows enhancers are active 
regardless of Wnt3a activation. When compared to the 
expression level of the negative control which has no TCF/LEF 
binding sites, three enhancers showed significant expression 
levels without added recombinant Wnt3a protein. These 
enhancers include the positive control (p-value=0.0047), Errfil 
(p-value=0.0131), and Fosl2-H (p-value=0.0023).  
Conclusions and Next Steps 
 
Through diagnostic digests using the appropriate restriction enzymes, we were able to identify and isolate the correct inserts, properly transfect them into UMR host cells, and 
quantify transgene expression through a luciferase reporter gene. Cloning enhancers into expression plasmids was successful, and the preliminary data from this experiment 
showed that there was at least one enhancer that significantly up-regulated transgenic expression in the presence of Wnt3a. The Topflash plasmid positive control has seven 
TCF/LEF binding sites which aided in significantly up-regulating expression in the presence of Wnt3a (p-value=0.0106). The Bhlhe40 enhancer also showed a significant 
increase in transgenic expression (p-value=0.0098). To increase the reproducibility of this experiment, future studies might include plating a higher concentration of cells for 
transfection and letting them transfect for a longer period of time. These validated enhancers further our understanding of transcriptional regulation by Wnt signaling, and will 
be used to improve conditions for validation of more putative enhancers in the future. These findings will also be used to examine relationships between Wnt-inducible 
enhancers and predicted phenotypes such as bone formation. These Wnt inducible enhancers may have additional effects in humans and may be sites for developmental control.  
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Create enhancer-expression constructs 
 
 
• Design primers and PCR amplify putative enhancers  
• Clone enhancers into expression plasmids 
• Identify correct inserts using restriction  
     enzyme digests  
 
 
          Determine if enhancers are Wnt inducible 
 
• Prep DNA for transfection 
• Grow cells for transfection  while learning aseptic  
      tissue culture techniques 
• Transform UMR cells with enhancer clones 
• Treat transfected  clones with Wnt3a 
• Quantify transgene expression via luciferase reporter gene 
• Determine if transfected clones are Wnt3a inducible 
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Figure 4. Topflash plasmid  
Figure 2. Function and location of  
enhancers on a chromosome 
Figure 3. Selection criteria for  
Wnt inducible enhancers 
Figure 7.  Expression level in relative light units of reporter gene 
driven by enhancer constructs in the presence of Wnt3a. 
Comparing stimulated and unstimulated expression driven by 
enhancers. Increase fold change indicates enhancers are active 
due to Wnt3a activation. The Topflash plasmid positive control 
showed significant up-regulation of transgenic expression in the 
presence of Wnt3a protein (p-value=0.0106). This is in 
concurrence with its seven TCF/LEF binding sites which greatly 
increase the amount of Wnt-signaling. Bhlhe40 (p-value=0.0098) 
also experienced a significant increase in transgenic expression.  
Figure 5. Gel electrophoresis for diagnostic 
digest shows positive screening results after 
cloning with the appropriate enhancer inserts. 
First lane shows a 1KB+ molecular weight 
ladder as a reference for DNA fragment size. 
Large molecular weight bands show the vector 
backbone and circled bands show successful 
inserts.  
IM release number: LLNL-POST-675632 
Figure 1. When Wnt receptor complexes 
are not bound by ligands, β-catenin is 
targeted for rapid destruction and 
transcription of Wnt target genes is 
inhibited. Once bound by Wnt, a co-
receptor complex activates the canonical 
signaling pathway stabilizing β-catenin 
and promotes the transcription of Wnt 
target genes.  
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